85 related articles for article (PubMed ID: 20646335)
1. Updating the physiology, exploration and disease relevance of complement factor H.
Buhé V; Loisel S; Pers JO; Le Ster K; Berthou C; Youinou P
Int J Immunopathol Pharmacol; 2010; 23(2):397-404. PubMed ID: 20646335
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic Tests Exploring Factor H Functional Activities.
Chabannes M; Togarsimalemath SK; Dragon-Durey MA
Methods Mol Biol; 2021; 2227():69-81. PubMed ID: 33847932
[TBL] [Abstract][Full Text] [Related]
4. Hijacking Factor H for Complement Immune Evasion.
Moore SR; Menon SS; Cortes C; Ferreira VP
Front Immunol; 2021; 12():602277. PubMed ID: 33717083
[TBL] [Abstract][Full Text] [Related]
5. Recombinant generation of two fragments of the rat complement inhibitory factor H [FH(SCR1-7) and FH(SCR1-4)] and their structural and functional characterization in comparison to FH isolated from rat serum.
Demberg T; Heine I; Götze O; Altermann WW; Seliger B; Schlaf G
Histol Histopathol; 2006 Jan; 21(1):93-102. PubMed ID: 16267790
[TBL] [Abstract][Full Text] [Related]
6. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.
Jarva H; Jokiranta TS; Hellwage J; Zipfel PF; Meri S
J Immunol; 1999 Oct; 163(7):3957-62. PubMed ID: 10490997
[TBL] [Abstract][Full Text] [Related]
7. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family.
Poolpol K; Orth-Höller D; Speth C; Zipfel PF; Skerka C; de Córdoba SR; Brockmeyer J; Bielaszewska M; Würzner R
Mol Immunol; 2014 Mar; 58(1):77-84. PubMed ID: 24317278
[TBL] [Abstract][Full Text] [Related]
9. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.
Nozal P; Garrido S; Alba-Domínguez M; Espinosa L; Peña A; Córdoba SR; Sánchez-Corral P; López-Trascasa M
Mol Immunol; 2014 Apr; 58(2):194-200. PubMed ID: 24378252
[TBL] [Abstract][Full Text] [Related]
10. Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-Factor H complex.
Heurich M; Preston RJ; O'Donnell VB; Morgan BP; Collins PW
Thromb Res; 2016 Sep; 145():84-92. PubMed ID: 27513882
[TBL] [Abstract][Full Text] [Related]
11. Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology.
Józsi M; Manuelian T; Heinen S; Oppermann M; Zipfel PF
Histol Histopathol; 2004 Jan; 19(1):251-8. PubMed ID: 14702193
[TBL] [Abstract][Full Text] [Related]
12. Functional anatomy of complement factor H.
Makou E; Herbert AP; Barlow PN
Biochemistry; 2013 Jun; 52(23):3949-62. PubMed ID: 23701234
[TBL] [Abstract][Full Text] [Related]
13. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
[TBL] [Abstract][Full Text] [Related]
14. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
[TBL] [Abstract][Full Text] [Related]
15. Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.
Banda NK; Mehta G; Ferreira VP; Cortes C; Pickering MC; Pangburn MK; Arend WP; Holers VM
J Immunol; 2013 Apr; 190(7):3560-9. PubMed ID: 23436934
[TBL] [Abstract][Full Text] [Related]
16. Biophysical analysis of sialic acid recognition by the complement regulator Factor H.
Schmidt CQ; Hipgrave Ederveen AL; Harder MJ; Wuhrer M; Stehle T; Blaum BS
Glycobiology; 2018 Oct; 28(10):765-773. PubMed ID: 29982679
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of Factor H as a Novel Complement Evasion Strategy for Blood-Stage Plasmodium falciparum Infection.
Kennedy AT; Schmidt CQ; Thompson JK; Weiss GE; Taechalertpaisarn T; Gilson PR; Barlow PN; Crabb BS; Cowman AF; Tham WH
J Immunol; 2016 Feb; 196(3):1239-48. PubMed ID: 26700768
[TBL] [Abstract][Full Text] [Related]
18. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.
Cheng ZZ; Hellwage J; Seeberger H; Zipfel PF; Meri S; Jokiranta TS
Mol Immunol; 2006 Mar; 43(7):972-9. PubMed ID: 16023208
[TBL] [Abstract][Full Text] [Related]
19. Complement factor H modulates the activation of human neutrophil granulocytes and the generation of neutrophil extracellular traps.
Schneider AE; Sándor N; Kárpáti É; Józsi M
Mol Immunol; 2016 Apr; 72():37-48. PubMed ID: 26938503
[TBL] [Abstract][Full Text] [Related]
20. A Family Affair: Addressing the Challenges of Factor H and the Related Proteins.
Poppelaars F; Goicoechea de Jorge E; Jongerius I; Baeumner AJ; Steiner MS; Józsi M; Toonen EJM; Pauly D;
Front Immunol; 2021; 12():660194. PubMed ID: 33868311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
